Lanean...
Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma
2015 was a groundbreaking year for the multiple myeloma community partly due to the breakthrough approval of the first two monoclonal antibodies in the treatment for patients with relapsed and refractory disease. Despite early disappointments, monoclonal antibodies targeting CD38 (daratumumab) and s...
Gorde:
| Argitaratua izan da: | Antibodies (Basel) |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6698817/ https://ncbi.nlm.nih.gov/pubmed/31548533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib6040018 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|